An immune gene signature to predict prognosis and immunotherapeutic response in lung adenocarcinoma

Lung adenocarcinoma is one of the most common malignant tumors worldwide. The purpose of this study was to construct a stable immune gene signature for prediction of prognosis (IGSPP) and response to immune checkpoint inhibitors (ICIs) therapy in LUAD patients. Five genes were screened by weighted g...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Hongquan, Lin, Renxi, Lin, Weibin, Chen, Qing, Ye, Dongjie, Li, Jing, Feng, Jinan, Cheng, Wenxiu, Zhang, Mingfang, Qi, Yuanlin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9114138/
https://www.ncbi.nlm.nih.gov/pubmed/35581376
http://dx.doi.org/10.1038/s41598-022-12301-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9114138/
https://www.ncbi.nlm.nih.gov/pubmed/35581376
http://dx.doi.org/10.1038/s41598-022-12301-6

Ejemplares similares